Oil prices are falling on Mideast hopes, per WSJ, helping stocks rebound after Friday's selloff.
Intel's steep drop and a tech selloff drove the decline, per Yahoo Finance and Kiplinger.
Nasdaq dives as Amazon and Intel earnings fuel a tech rout, per Yahoo Finance and Business Insider.
Per Bloomberg, the Nasdaq 100 fell 1.5% as AI trade shows new cracks, and per Kiplinger the Nasdaq dropped on Alphabet's rare double miss.
Per CNBC, the S&P 500 is heading for its first loss in four days as Alphabet and Caterpillar fall after earnings.
Per Investopedia, stocks closed higher after the Fed held rates steady, with Treasury yields rising.
Per Yahoo Finance, the Nasdaq is wavering while the S&P 500 and Dow climb ahead of the Fed decision and Big Tech earnings.
SPYheating up fast
Retail traders are piling into the broad index bet, with 454 comments on the S&P 500 tracker topping every single stock today. Chipmaker chatter stays bullish, while the mood on the software giant and the EV maker has turned bearish and the iPhone maker splits the room.
Source: RedditNVDAsouring fast
Moderna is pulling more chatter than the rest of the board combined, and the mood there is bearish even as its pipeline headlines pile up. Nvidia is souring fast, while traders stay split on Meta and Alphabet and keep leaning bullish on the broad index.
Source: Redditbuy low sell high? good idea, might have to try it
A 0DTE SPY and SPX run from $48,000 to $900,000 in two months is the kind of post that pulls new traders into the riskiest product on the board. The top comments are already picking apart the screenshot, and nobody posts the accounts that went to zero.
Retirement savers who never chose IDEXX Laboratories (NASDAQ:IDXX | IDXX Price Prediction) got a lift from it anyway on Monday. The veterinary diagnostics company was up 20.2% in the regular session as…
Barron’s put two questions to 81 professional investors, and the answers point in different directions. Half are bullish on American stocks over the coming year. Yet only 37% believe today’s AI infrastructure…
Fundstrat’s Tom Lee believes dip buyers are waiting for a specific date. “I think people are going to plan to buy the dip,” Lee said. “But as strange as it sounds, I…
A $10,000 bet placed at the right moment could have turned into life-changing money, but the same bet placed just a few years later tells a completely different story about which asset…
Sam Daodu American households are squeezing more of their paychecks into rent and groceries than they have in over a decade, and the pressure is already reshaping where investors park their money and where…
Two Fed officials broke from the crowd within 48 hours of the FOMC hold, and what they signaled about timing puts SPY's year-to-date gains directly in the crosshairs.
A record $2.24 trillion has flooded into ETFs worldwide this year, yet despite thousands of funds competing for that money, nearly half of it ended up in the hands of just three…
UPS rode a pandemic surge to all-time highs, then spent years in freefall while its biggest rival kept stealing volume. Whether a decade of generous dividends was enough to make loyal shareholders…
On November 7, 2025, JFrog (NASDAQ:FROG | FROG Price Prediction) was one of the most closely followed names in software. The company had just reported third-quarter revenue of $136.91 million, ahead of…
Intel's brutal Friday selloff did not stop at its own ticker. If you hold a popular index or sector ETF, the damage landed in your account too, and the overlap across funds…
A record theft at Binance and a weak trading quarter are pulling crypto stocks lower. Coinbase Global (NASDAQ:COIN | COIN Price Prediction) stock is at $142.50 in morning trading, down 11%. The…
Intel has shed a fifth of its value in a single month while its rivals barely flinched, yet one analyst sees a 70% surge coming. The catch is a collision between a…
JPMorgan manages two very different ETFs, and the gap between their long-term results raises a question every retiree holding the popular monthly-income fund should think through carefully before their next contribution.
Two income funds, one blended yield, and a fixed monthly target: the math works on paper, but the risks hiding inside this two-fund setup could quietly widen the gap when markets turn…
AbbVie built its empire on a single blockbuster drug, then watched biosimilars gut it almost overnight. Whether the replacement pipeline saved investors or left them holding the bag depends on when they…
